• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物群与糖代谢:多方面和多角度的联系。

Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives.

机构信息

Internal Medicine Department, Hospital of Marcianise, ASL Caserta, 81037 Caserta, Italy.

Internal Medicine Department, Hospital of Latina, ASL Latina, 04100 Latina, Italy.

出版信息

Int J Mol Sci. 2023 Jun 20;24(12):10409. doi: 10.3390/ijms241210409.

DOI:10.3390/ijms241210409
PMID:37373556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10299495/
Abstract

The global prevalence of overweight and obesity has dramatically increased in the last few decades, with a significant socioeconomic burden. In this narrative review, we include clinical studies aiming to provide the necessary knowledge on the role of the gut microbiota in the development of diabetic pathology and glucose-metabolism-related disorders. In particular, the role of a certain microbial composition of the fermentative type seems to emerge without a specific link to the development in certain subjects of obesity and the chronic inflammation of the adipose tissues, which underlies the pathological development of all the diseases related to glucose metabolism and metabolic syndrome. The gut microbiota plays an important role in glucose tolerance. Conclusion. New knowledge and new information is presented on the development of individualized therapies for patients affected by all the conditions related to reduced glucose tolerance and insulin resistance.

摘要

在过去的几十年中,超重和肥胖的全球患病率显著增加,这给社会经济带来了巨大负担。在这篇叙述性综述中,我们纳入了旨在提供关于肠道微生物群在糖尿病病理和葡萄糖代谢相关疾病发展中作用的必要知识的临床研究。特别是,发酵型特定微生物组成的作用似乎出现了,而与肥胖和脂肪组织慢性炎症的发展并没有特定的联系,这是与葡萄糖代谢和代谢综合征相关的所有疾病的病理发展的基础。肠道微生物群在葡萄糖耐量中起着重要作用。结论。为受所有与葡萄糖耐量降低和胰岛素抵抗相关的疾病影响的患者提供了新的知识和信息,以制定个体化治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00a/10299495/f0b3ac317678/ijms-24-10409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00a/10299495/46d91819fe50/ijms-24-10409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00a/10299495/f0b3ac317678/ijms-24-10409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00a/10299495/46d91819fe50/ijms-24-10409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00a/10299495/f0b3ac317678/ijms-24-10409-g002.jpg

相似文献

1
Microbiota and Glucidic Metabolism: A Link with Multiple Aspects and Perspectives.微生物群与糖代谢:多方面和多角度的联系。
Int J Mol Sci. 2023 Jun 20;24(12):10409. doi: 10.3390/ijms241210409.
2
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.肠道微生物群控制脂肪组织扩张、肠道屏障和葡萄糖代谢:对使用益生元的分子靶点和干预措施的新见解。
Benef Microbes. 2014 Mar;5(1):3-17. doi: 10.3920/BM2012.0065.
3
Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota.饮食诱导肥胖小鼠中血管生成素样蛋白 4 (ANGPTL4) 的缺失部分通过肠道微生物群将内脏肥胖与葡萄糖不耐受解耦。
Diabetologia. 2018 Jun;61(6):1447-1458. doi: 10.1007/s00125-018-4583-5. Epub 2018 Mar 3.
4
[Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].[肠道微生物群的生理模式。肠道菌群失调在肥胖、胰岛素抵抗、糖尿病和代谢综合征中的作用]
Orv Hetil. 2016 Jan 3;157(1):13-22. doi: 10.1556/650.2015.30296.
5
Fat and not sugar as the determining factor for gut microbiota changes, obesity, and related metabolic disorders in mice.脂肪而非糖是小鼠肠道微生物群变化、肥胖及相关代谢紊乱的决定因素。
Am J Physiol Endocrinol Metab. 2023 Jan 1;324(1):E85-E96. doi: 10.1152/ajpendo.00141.2022. Epub 2022 Dec 14.
6
Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?肥胖、糖尿病与肠道微生物群:卫生假说的扩展?
Diabetes Care. 2010 Oct;33(10):2277-84. doi: 10.2337/dc10-0556.
7
Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond.葡萄糖代谢:关注肠道微生物群、内源性大麻素系统及其他方面。
Diabetes Metab. 2014 Sep;40(4):246-57. doi: 10.1016/j.diabet.2014.02.004. Epub 2014 Mar 14.
8
Metabolites of Gut Microbiota and Possible Implication in Development of Diabetes Mellitus.肠道微生物群的代谢产物及其在糖尿病发病机制中的可能作用。
J Agric Food Chem. 2022 May 25;70(20):5945-5960. doi: 10.1021/acs.jafc.1c07851. Epub 2022 May 12.
9
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.常见代谢紊乱和遗传性胰岛素抵抗中的代谢与胰岛素信号传导
Dan Med J. 2014 Jul;61(7):B4890.
10
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?肠道微生物群与肥胖、胰岛素抵抗和 2 型糖尿病的相互作用:肠道微生物群是否与胰岛素抵抗共同进化?
Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d.

引用本文的文献

1
Gender Differences in Insulin Resistance: New Knowledge and Perspectives.胰岛素抵抗中的性别差异:新知识与新视角。
Curr Issues Mol Biol. 2023 Sep 27;45(10):7845-7861. doi: 10.3390/cimb45100496.

本文引用的文献

1
Obese visceral fat tissue inflammation: from protective to detrimental?肥胖内脏脂肪组织炎症:从保护到有害?
BMC Med. 2022 Dec 27;20(1):494. doi: 10.1186/s12916-022-02672-y.
2
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability.短链脂肪酸代谢与肠道微生物群和遗传变异性的关系。
Nutrients. 2022 Dec 16;14(24):5361. doi: 10.3390/nu14245361.
3
Distinct Changes in Microbiota-Mediated Intestinal Metabolites and Immune Responses Induced by Different Antibiotics.不同抗生素诱导的微生物群介导的肠道代谢物和免疫反应的显著变化。
Antibiotics (Basel). 2022 Dec 6;11(12):1762. doi: 10.3390/antibiotics11121762.
4
Adipose Tissue Macrophages Modulate Obesity-Associated β Cell Adaptations through Secreted miRNA-Containing Extracellular Vesicles.脂肪组织巨噬细胞通过分泌含有 miRNA 的细胞外囊泡调节肥胖相关的β细胞适应性改变。
Cells. 2021 Sep 17;10(9):2451. doi: 10.3390/cells10092451.
5
Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic β cells.脂肪细胞衍生的细胞外囊泡调节胰腺β细胞的存活和功能。
JCI Insight. 2021 Mar 8;6(5):141962. doi: 10.1172/jci.insight.141962.
6
Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance.介导线粒体自噬的脂肪炎症促进伴有肝胰岛素抵抗的 2 型糖尿病。
J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20201416.
7
Retinol-Binding Protein 4 Activates STRA6, Provoking Pancreatic β-Cell Dysfunction in Type 2 Diabetes.视黄醇结合蛋白 4 激活 STRA6,引发 2 型糖尿病中胰腺 β 细胞功能障碍。
Diabetes. 2021 Feb;70(2):449-463. doi: 10.2337/db19-1241. Epub 2020 Nov 16.
8
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.肠道微生物群作为肥胖和 2 型糖尿病代谢性炎症的触发因素。
Front Immunol. 2020 Oct 16;11:571731. doi: 10.3389/fimmu.2020.571731. eCollection 2020.
9
The Gut Microbiota and Inflammation: An Overview.肠道微生物群与炎症:概述。
Int J Environ Res Public Health. 2020 Oct 19;17(20):7618. doi: 10.3390/ijerph17207618.
10
Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance.肥胖症患者脂肪组织中白细胞介素 2 表达升高与代谢性炎症和胰岛素抵抗有关。
Sci Rep. 2020 Oct 1;10(1):16364. doi: 10.1038/s41598-020-73347-y.